SMC u-turn backs Roche’s Kadcyla for breast cancer
admin 11th April 2017 Uncategorised 0Women in Scotland will be among the first in the UK to have routine NHS access to Roche’s breast cancer drug Kadcyla after a landmark u-turn by cost regulators endorsed funding for the drug.
More: SMC u-turn backs Roche’s Kadcyla for breast cancer
Source: News